AstraZeneca has introduced FluMist Home, a nasal spray flu vaccine available for self-administration at home in 34 states. Approved by the FDA, Flu...
AstraZeneca has launched the FluMist Home program, allowing Americans to receive their annual flu vaccine via nasal spray directly at home. This in...
AstraZeneca has announced the launch of an at-home delivery option for FluMist, its nasal spray flu vaccine. Previously available only at pharmacie...
AstraZeneca has launched the FluMist Home program, allowing Americans to receive nasal flu vaccines directly at home, bypassing traditional healthc...
FluMist Home, a nasal spray flu vaccine, has been launched by AstraZeneca, allowing individuals to administer the vaccine at home. This initiative ...
AstraZeneca's FluMist Home program has launched, providing a nasal spray flu vaccine for home use. This initiative targets individuals aged 2 to 49...
FluMist Home, a nasal spray flu vaccine, has been launched by AstraZeneca, allowing individuals to self-administer the vaccine at home. Available f...
Glaukos Corporation, a company specializing in ophthalmic pharmaceuticals and medical technology, has announced its participation in the upcoming W...
Vinay Prasad has returned to the FDA as chief of the Center for Biologics Evaluation and Research, following his departure amid controversy over Sa...
The U.S. Centers for Disease Control and Prevention has issued a travel warning for Americans visiting Finland, Germany, Spain, the United Kingdom,...